These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24352635)

  • 21. Patient preferences for hepatitis B therapy.
    Lim SG; Aung MO; Chung SW; Soon CS; Mak BH; Lee KH
    Antivir Ther; 2013; 18(5):663-70. PubMed ID: 23232291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometrics of chronic liver disease questionnaire in Chinese chronic hepatitis B patients.
    Zhou KN; Zhang M; Wu Q; Ji ZH; Zhang XM; Zhuang GH
    World J Gastroenterol; 2013 Jun; 19(22):3494-501. PubMed ID: 23801844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners' perspective.
    Wallace J; Hajarizadeh B; Richmond J; McNally S
    Aust N Z J Public Health; 2013 Oct; 37(5):405-10. PubMed ID: 24090321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of patients with chronic hepatitis B who do not meet criteria for antiviral treatment at presentation.
    Yapali S; Talaat N; Fontana RJ; Oberhelman K; Lok AS
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):193-201.e1. PubMed ID: 25041863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model.
    Ma GX; Zhu L; Lu W; Tan Y; Truehart J; Johnson C; Handorf E; Nguyen MT; Yeh MC; Wang MQ
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors.
    Li ZQ; Hu CL; Yu P; Gu XY; Zhang JJ; Li H; Zhang HY; Lv J; Liu YM; Zeng QL; Yan JY; Yu ZJ; Zhang Y
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):311-318. PubMed ID: 28237828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
    Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
    Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients.
    Pan CQ; Hu KQ; Tsai N
    Antivir Ther; 2013; 18(7):841-52. PubMed ID: 23178555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic Hepatitis B (CHB) through a Multicomponent Culturally Tailored Intervention: A Randomized Controlled Trial.
    Ma GX; Zhu L; Lu W; Handorf E; Tan Y; Yeh MC; Johnson C; Guerrier G; Nguyen MT
    Healthcare (Basel); 2022 Oct; 10(10):. PubMed ID: 36292391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
    Toy M; Hutton D; Harris AM; Nelson N; Salomon JA; So S
    Clin Infect Dis; 2022 Jan; 74(2):210-217. PubMed ID: 33956937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.
    Toy M; Salomon JA; Jiang H; Gui H; Wang H; Wang J; Richardus JH; Xie Q
    Hepatology; 2014 Jul; 60(1):46-55. PubMed ID: 24990105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore.
    Lacey LF; Gane E
    J Viral Hepat; 2007 Nov; 14(11):751-66. PubMed ID: 17927611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowing and telling: how African-Australians living with chronic hepatitis B understand hepatocellular carcinoma risk and surveillance.
    Allard N; Emery J; Cowie B; Furler J
    Aust J Prim Health; 2018 May; 24(2):141-148. PubMed ID: 29481766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical training fails to prepare providers to care for patients with chronic hepatitis B infection.
    Chao SD; Wang BM; Chang ET; Ma L; So SK
    World J Gastroenterol; 2015 Jun; 21(22):6914-23. PubMed ID: 26078568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical presentation and disease phases of chronic hepatitis B using conventional versus modified ALT criteria in Asian Americans.
    Hsu YN; Pan CQ; Abbasi A; Xia V; Bansal R; Hu KQ
    Dig Dis Sci; 2014 Apr; 59(4):865-71. PubMed ID: 24519522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals.
    Hyun CS; Ko O; Lee S; McMenamin J
    BMC Infect Dis; 2019 Jul; 19(1):638. PubMed ID: 31319805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy.
    Kim JH; Kim YD; Lee M; Jun BG; Kim TS; Suk KT; Kang SH; Kim MY; Cheon GJ; Kim DJ; Baik SK; Choi DH
    J Hepatol; 2018 Nov; 69(5):1066-1073. PubMed ID: 30075230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
    Martin P; Lau DT; Nguyen MH; Janssen HL; Dieterich DT; Peters MG; Jacobson IM
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2071-87.e16. PubMed ID: 26188135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.
    Choi J; Kim HJ; Lee J; Cho S; Ko MJ; Lim YS
    JAMA Oncol; 2019 Jan; 5(1):30-36. PubMed ID: 30267080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations of IFN-γ-inducible protein-10 with the risk of chronic hepatitis B and the efficacy of interferon therapy in Asians.
    Gong LL; Zhao BB; Fan WF; Gong LY; Chen CF; Liu JJ; Lu X
    Int J Clin Exp Pathol; 2015; 8(7):8367-75. PubMed ID: 26339406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.